Skip Ribbon Commands
Skip to main content
Menu
Dr Tay Kae Jack

Dr Tay Kae Jack

​MBBS, MRCS (Ed), MMed (Surg), MCI, FAMS (Urology)

Senior Consultant

Specialty: Surgery & Surgical Oncology, Urology

Clinical Interest: Uro-Oncology, Minimally Invasive Surgery

Conditions Treated by this Doctor:
Adrenal Gland Cancer, Bladder Cancer, Kidney Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer.

Clinical Appointments

  • Senior Consultant Urology Singapore General HospitalSingapore General Hospital
  • Senior Consultant Division of Surgery & Surgical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore

Profile

​Dr Tay Kae Jack is a Senior Consultant with the Department of Urology at the Singapore General Hospital.

Education

  • 2014: Fellow of the Academy of Medicine, Singapore (Urology)
  • 2014: Master in Clinical Investigation (National University Singapore - NUS)
  • 2012: Master in Medicine (Surgery) (NUS)
  • 2008: Member of the Royal College of Surgeons (Edinburgh)
  • 2005: Bachelor in Medicine and Bachelor in Surgery (NUS)

Professional Appointments and Committee Memberships

  • Consultant Urologic Surgeon, Department of Urology, Singapore General Hospital (SGH)
  • Clinical Faculty, Yong Loo Lin School of Medicine, National University of Singapore

Awards


  • College of Surgeons Gold Medal 2014
  • National Medical Research Council Research Training Fellowship Award 2014
  • Best Video Presentation, SUA Annual Scientific Meeting 2014, Robotic Transperineal Prostate Biopsy – Technique and outcomes
  • Best Video Presentation, World Congress of Endourology 2014, Robotic Transperineal Prostate Biopsy – Technique and outcomes 
  • Best Oral Clinical Presentation, SUA Annual Scientific Meeting 2013 Robotic transperineal saturation biopsy approximates the “truth” in low-risk prostate cancer.
  • Best Poster, Société Internationale d'Urologie Annual Meeting 2013 Robotic transperineal saturation biopsy approximates the “truth” in low-risk prostate cancer.
  • Best Oral Basic Science Presentation, SUA Annual Scientific Meeting 2013 The diagnostic and prognostic utility of an epigenetic PHYMA signature in prostate cancer.
  • Best Basic Science Poster, 1st Singhealth Surgical Congress and 19th Asian Congress of Surgery 2013 The diagnostic and prognostic utility of an epigenetic PHYMA signature in prostate cancer.
  • Best Oral Clinical Presentation, SUA Annual Scientific Meeting 2010 Is Contrast Enhanced Ultrasound a valid diagnostic tool for renal cell carcinoma in patients with renal impairment?

Research Interests

  • Prostate cancer
  • Prostate focal therapy
  • Prostate advanced imaging
  • Targeted biopsy and diagnostics

Publications

Publications

1.Passive cigarette smoking is a risk factor in cervical neoplasia.
 Gynecol Oncol. 2004 Apr;93(1):116-20. 
 Tay SK, Tay KJ
 PMID: 15047223 [PubMed - indexed for MEDLINE]

2.Right cholecysto-hepato-choledocho fistula: a new variant of type II Mirizzi syndrome?
Tay KJ, Chung AY
 ANZ J Surg. 2007 Sep;77(9):798-9. 
 PMID: 17685965 [PubMed - indexed for MEDLINE]

3.Is Contrast Enhanced Ultrasound a valid diagnostic tool for renal cell carcinoma in patients with renal impairment?
Tay KJ, Ho H, Low A, Cheng CW
 Ann Acad Med Singapore. 2012 Mar;41(3):127-8.
 PMID: 22538740 [PubMed - indexed for MEDLINE]

4.Prevailing Attitudes Towards Cancer: A Multicultural Survey in a Tertiary Outpatient Setting
Tay KJ, Nor Azhari BMZ, Cheng CW
 Ann Acad Med Singapore. 2013 Oct;42(10):492-8.
 PMID:24254235[PubMed - in process]

5.Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.
 Goh LK, Liem N, Vijayaraghavan A, Chen G, Lim PL, Tay KJ, Chang M, Low JS, Joshi A, Huang HH, Kalaw E, Tan PH, Hsieh WS, Yong WP, Alumkal J, Sim HG.
 PLoS One. 2014 Mar 13;9(3):e91666. doi: 10.1371/journal.pone.0091666. eCollection 2014.
 PMID:24626295[PubMed - in process]

6.The minimally invasive treatments for benign prostatic hyperplasia.
 Lim YW, Tay KJ, Ho SH
 Proceedings of Singapore Healthcare. 2014 (23): 65-73


Conference Papers

1.Prevailing attitudes towards cancer – a multicultural survey in a regional urology center.
Tay KJ, Nor Azhari BMZ, Cheng C
Presented as poster at Urofair 2010

2.Is Contrast Enhanced Ultrasound a valid diagnostic tool for renal cell carcinoma in patients with renal impairment?
Tay KJ, Ho H, Low A, Cheng CW
Presented at Urofair 2010 (Oral Clinical Presentation), Duke-NUS Scientific Congress 2010 (Poster) and American Urological Association 2010 (Moderated Poster)

3.Initial Experience with MRgfus Focal Therapy for Low-Risk Prostate 
 Cancer.
Tay KJ, Cheng C, Kwek JW, Thng CH, Lau W, Ho H, Khoo J, Kanaev SV, Gafton GI, Turkevich VG, Nosov AK
Presented at World Congress of Endourology 2011 (Moderated Poster)

4.Early outcomes of pathological T3 prostate cancer: A comparison of robotic versus open radical prostatectomy
Tay KJ, Sim HG, Ho H, Huang HH, Cheng CW
Presented at Urofair 2012 (Oral Clinical Presentation) and Duke-NUS Scientific Congress 2012 (Poster)

5.Continence outcomes after salvage radiotherapy for biochemical recurrence after radical prostatectomy
Tay KJ, Lim YW, Tan T, Sim HG
Presented at Urofair 2012 (Moderated Poster)

6.The diagnostic and prognostic utility of an epigenetic PHYMA signature in prostate cancer.
Tay KJ, Goh LK, Liem N, Chen G, Lim PL, Chang M, Low J, Joshi A, Geronimo C, Huang HH, Kalaw E, Tan PH, Hsieh Wenson, Yong WP, Alumkal J, Sim HG
Presented at Urofair 2013 (Oral Basic Science Presentation) and 19th Asian Congress of Surgery/ 1st Singhealth Surgical Congress (Basic Science Poster)

7.Robotic transperineal saturation biopsy approximates the “truth” in low-risk prostate cancer.
Tay KJ, Ho H, Huang HH, Law ZW, Koh ZJ, Yuen JS, Cheng CW
Presented at Urofair 2013 (Oral Clinical Presentation)

8.Dynamic Contrast Enhanced and Diffusion Weighted MRI correlate with higher grade prostate cancer with extracapsular extension.
Tay KJ, Yuen JS, Thng CH, Jara-Lazaro AR, Ho H, Law YM, Tan PH, Cheng CW
Presented at Urofair 2013 (Poster)

9.Robotic Transperineal Prostate Biopsy – Technique and outcomes (Video)
Tay KJ, Ho H, Yuen J, Cheng C
Presented at Urofair 2014 and AUA 2014 

10.A treatment journey of 108 men on active surveillance for prostate cancer: Why men change?
Tay KJ, Huang HH, Lee LS, Lau W, Cheng C, Yuen J
Presented at Urofair 2014 (Oral Clinical Presentation)


Research Trials